Watch My Full Video Chart Analysis For Free On Youtube! You Can Find The Link Below!
SGYP seems to be setting up for a big big move. The Squeeze Momentum Indicator has been forming a triangle which is now about to close and the crosses in the indicator have been black for some time meaning that a release of the squeeze should be about to manifest. My guess is that spike will be to the upside, and it could go as high as 3.60$ (90%+ appreciation),...
Expected upward trend ahead of 24 January PDUFA label extension for Trulance
seems like a pretty clear bullflag to me let me know what you guys thing
SGYP is in uptrend on 4h and it has almost completed an AB=CD pattern. It's in a strong resistance area, so i'm expecting a retrace. Possible bearish divergence.
Shares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products. It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company,...
SGYP has a daily bullish bat in progress but I also looked at the weekly and notice the higher market structure lows which is setting up a weekly seed wave on a price breakout through $4.70. This sets the upside targets on a second leg up at $5.28, $5.60 and $6.06 (the 1.27-1.618 fibs). There are many near-term fundamental catalysts: Paulson & Co. adding 3.2...
SGYP setting up a daily bullish bat LONG pattern going into May 20th, 2015, conference. Paulson & Co. took a 2 million share long position according to 13-F. Company has two GI drugs in phase 3 pipeline and is open to acquisition as peer Salix was acquired recently. $4.84-$5.24 upside target projections.